Home / Events /

Almac Clinical Services and Clinical Technologies are delighted to be co-exhibiting at OCT/CTS East Asia 2025 (Korea), from the 2nd – 3rd December 2025 in Seoul, South Korea.

Visit Booth 1, where Kate Park, Yeeun Noh, Matt Do and Kevin So are ready to share how Almac’s tailored Clinical Trial Solutions can help drive success of your next study.

About the OCT/CTS East Asia 2025 (Korea)

The leading Clinical trials supply conference in East Asia is returning in 2025. With a focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials, this is an event not to be missed.

Unlike other conferences, this event focuses especially on the regional pharmaceutical business in Asia, highlighting the industry’s current difficulties as well as its exciting innovations and growth prospects.

Not only will the audience be discussing clinical partnership and supply challenges, but we also have the Outsourcing Clinical Trials Korea conference co-located with the event to give you the opportunity to define an end-to-end clinical strategy.

Meet and network with over 250 senior industry decision makers during the dedicated networking breaks, round tables and interactive sessions.

For more information and to register for the event, please visit the OCT/CTS East Asia 2025 website.

Share this event

Share on Facebook Share on Twitter Share on LinkedIn
Kate Park

Kate Park

Director - Business Development

Email

Director – Business Development | Almac Clinical Services

Yeeun Noh

Yeeun Noh

Business Development Manager

Email

Business Development Manager | Almac Clinical Services

Matthew Do

Matthew Do

Director - APAC Operations

Email

Director – APAC Operations | Almac Clinical Services
Kevin So

Kevin So

Key Account Manager | Business Development Manager

Email

Key Account Manager | Business Development Manager | Almac Clinical Technologies

Where can you find us?

We look forward to meeting you at booth 1

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies